About the Council
The Healthcare Biotechnology Council works to highlight the potential of new biotechnology solutions, the pipeline of their applications and defines the implications these new tools will have on the European regulatory and legislative framework.
New advances in biological sciences combined with the acceleration of technological applications are transforming how healthcare is delivered to patients.
The Healthcare Council develops proposals related to the value of innovation and the role of biotechnology, intellectual property protection, regulatory competitiveness, and access to medicines. The working groups provide technical expertise to deliver our long-term priorities.
The Council delivers the Patient BioForum as the platform of exchange of views between patient organisations, healthcare biotechnology members and policymakers.
The Council also engages with the EMA through annual bilateral meetings and regular participation to activities to ensure regulatory framework is fit for biotechnology innovation.
The Council meets three times per year to issue strategic advice and overall vision. It is supported by Working Groups across priority topics.
Healthcare Biotechnology in Action
PUBLICATIONS
View all